Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections

Sally N. Adebamowo,Adebowale Adeyemo,Amos Adebayo,Peter Achara,Bunmi Alabi,Rasheed A. Bakare,Ayotunde O. Famooto,Kayode Obende,Richard Offiong,Olayinka Olaniyan,Sanni Ologun,Charles Rotimi,Saurayya S. Abdullahi,Maryam Abdulsalam,Ruxton Adebiyi,Victor Adekanmbi,Bukunmi Adelekun,Segun Adeyemo,Gerald Akabueze,Bernice Akpobome,Stella Akpomiemie,Gabriel O. Alabi,Chinyere Anichebe,Claire Anyanwu,Miriam C. Ayogu,Dorcas J. Bako,Patience Bamisaiye,Nkechi U. Blessing,Osa A. Chinye,Patrick Dakum,Eileen Dareng,Grace Dwana,Juliet I. Erhunmwonsere,Emelda O. Eze,Tolani A. Fagbohun,Temitope Filade,Toluwalope Gbolahan,Gloria C. Anaedobe,Stella Ibezim,Racheal Iwaloye,Jesse James,Dayo Kehinde,Fiyinfoluwa Makinde,Jessica Mase,Charles Mensah,Florence A. Nwoko,Kayode Obende,George Odonye,Folake Odubore,Funmi Odunyemi,Michael Odutola,Uzoamaka Oguama,Tochukwu Oguoma,Temitayo Oladimeji,Toyosi Olawande,Temitope Olukomogbon,Sefunmi Oluwole,Gladys Omenuko,Nkiruka Onwuka,Yinka Owoade,Thelma C. Ugorji,Syntyche Yohanna,Ibrahim Yusuf,Clement A. Adebamowo,ACCME Research Group as part of the H3Africa Consortium

DOI: https://doi.org/10.1038/s41431-023-01521-7

2024-01-11

European Journal of Human Genetics

Abstract:Genetic variants that underlie susceptibility to cervical high-risk human papillomavirus (hrHPV) infections are largely unknown. We conducted discovery genome-wide association studies (GWAS), replication, meta-analysis and colocalization, generated polygenic risk scores (PRS) and examined the association of classical HLA alleles and cervical hrHPV infections in a cohort of over 10,000 women. We identified genome-wide significant variants for prevalent hrHPV around LDB2 and for persistent hrHPV near TPTE2, SMAD2, and CDH12, which code for proteins that are significantly expressed in the human endocervix. Genetic variants associated with persistent hrHPV are in genes enriched for the antigen processing and presentation gene set. HLA-DRB1*13:02, HLA-DQB1*05:02 and HLA-DRB1*03:01 were associated with increased risk, and HLA-DRB1*15:03 was associated with decreased risk of persistent hrHPV. The analyses of peptide binding predictions showed that HLA-DRB1 alleles that were positively associated with persistent hrHPV showed weaker binding with peptides derived from hrHPV proteins and vice versa. The PRS for persistent hrHPV with the best model fit, had a P-value threshold (PT) of 0.001 and a p-value of 0.06 (-log10(0.06) = 1.22). The findings of this study expand our understanding of genetic risk factors for hrHPV infection and persistence and highlight the roles of MHC class II molecules in hrHPV infection.

genetics & heredity,biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to explore the genetic variations associated with high-risk human papillomavirus (hrHPV) infection and its persistence in the cervix. The study achieves this goal through genome-wide association studies (GWAS), replication studies, meta-analyses, colocalization analyses, generation of polygenic risk scores (PRS), and examining the relationship between classical HLA alleles and cervical hrHPV infection.

The main research questions include:
1. **Discovering new genetic variations**: Identifying genomic variations significantly associated with the prevalence and persistence of cervical hrHPV infection.
2. **Understanding the functional significance of genetic variations**: Investigating the expression of these genetic variations in cervical tissues and their potential functional roles.
3. **HLA association**: Examining the relationship between classical HLA alleles and cervical hrHPV infection, particularly their roles in antigen processing and presentation.
4. **Polygenic risk scores**: Constructing polygenic risk score models to assess the risk of individuals developing cervical hrHPV infection.

The study results identified several genomic regions significantly associated with the prevalence and persistence of cervical hrHPV infection, such as variations near LDB2, TPTE2, SMAD2, and CDH12. It also revealed a strong association between HLA-DRB1 and DQB1 alleles and the persistence of hrHPV infection. Additionally, a polygenic risk score model was constructed to predict the risk of persistent hrHPV infection. These findings help expand our understanding of the genetic risk factors for hrHPV infection and highlight the role of MHC class II molecules in hrHPV infection.